Global MarketsMay 6 at 07:11 AM

Novo Nordisk (NOVOB DC) exec says early oral obesity trends look incremental rather than cannibalistic and roughly 80% of Wegovy pill users are GLP-1 naive

News detail

Launch is bringing in new prescribers and new patients, and switching from competitive products appears to be more meaningful than switching from injectable Wegovy.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLY Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

U.S. Economy